Quick Answer
ICU MEDICAL INC/DE reported Research And Development Expense of $87.50 million for the year ending 2025.
- ICU MEDICAL INC/DE showed a decrease of -1.3% in Research And Development Expense from 2024 to 2025.
- This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), ICU MEDICAL INC/DE's Research And Development Expense has grown by 1,714.5%.
- Historical annual values: Fiscal year 2025: $87.50 million | Fiscal year 2024: $88.62 million | Fiscal year 2023: $85.34 million | Fiscal year 2022: $92.98 million | Fiscal year 2021: $47.50 million | Fiscal year 2020: $42.95 million | Fiscal year 2019: $48.61 million | Fiscal year 2018: $52.87 million | Fiscal year 2017: $51.25 million | Fiscal year 2016: $12.96 million | Fiscal year 2015: $15.71 million | Fiscal year 2014: $18.33 million | Fiscal year 2013: $12.41 million | Fiscal year 2012: $10.63 million | Fiscal year 2011: $8.59 million | Fiscal year 2010: $4.68 million | Fiscal year 2009: $2.65 million | Fiscal year 2008: $4.82 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: